Carter Todd Alfred 4
4 · Voyager Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Carter Todd Alfred
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-02-09+38,500→ 91,594 total - Award
Stock Option (Right to Buy)
2024-02-09+77,000→ 77,000 totalExercise: $7.60Exp: 2034-02-09→ Common Stock (77,000 underlying)
Footnotes (2)
- [F1]Consists of shares of common stock issuable under an aggregate of 38,500 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.
- [F2]This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service.